phase 1_initiation
saveNovo Nordisk AS — cagrilintide hydrochloride (Phase I Trial Initiation)
community read0 votes
Therapy area: Metabolic Disorders. Indication: Obesity, Overweight
Data sources
globaldata
Found something off?
same company · ±60 days · 5
- phase 2 initiationzalfermin: Novo Nordisk AS — zalfermin (Phase II Trial Initiation)Apr 25, 2026
- approvalWEGOVY (SEMAGLUTIDE) — FDA approvalMar 19, 2026
- approvalWEGOVY (SEMAGLUTIDE) — FDA approvalMar 19, 2026
- recallHarbin Jixianglong Biotech Co., Ltd. recall (Cls II)Mar 11, 2026
- recallHarbin Jixianglong Biotech Co., Ltd. recall (Cls II)Mar 11, 2026
comments(0)
5-min edit window · permanent after that